Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K6BI
|
|||
| Former ID |
DIB019412
|
|||
| Drug Name |
PMID22115617C2c
|
|||
| Synonyms |
TMCB; 905105-89-7; TMCB/; GTPL8140; DTXSID50677589; MolPort-019-939-193; BS0265; BDBM50359846; ZINC58638742; ABP000318; AKOS024457742; K66
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C11H9Br4N3O2
|
|||
| Canonical SMILES |
CN(C)C1=NC2=C(N1CC(=O)O)C(=C(C(=C2Br)Br)Br)Br
|
|||
| InChI |
1S/C11H9Br4N3O2/c1-17(2)11-16-9-7(14)5(12)6(13)8(15)10(9)18(11)3-4(19)20/h3H2,1-2H3,(H,19,20)
|
|||
| InChIKey |
PHAOTASRLQMKBE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 905105-89-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Casein kinase II alpha (CSNK2A1) | Target Info | Inhibitor | [1] |
| Casein kinase II alpha prime (CSNK2A2) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Ribosome biogenesis in eukaryotes | |||
| NF-kappa B signaling pathway | ||||
| Wnt signaling pathway | ||||
| Adherens junction | ||||
| Tight junction | ||||
| Measles | ||||
| Herpes simplex infection | ||||
| Epstein-Barr virus infection | ||||
| NetPath Pathway | FSH Signaling Pathway | |||
| Pathway Interaction Database | BCR signaling pathway | |||
| Atypical NF-kappaB pathway | ||||
| DNA-PK pathway in nonhomologous end joining | ||||
| Presenilin action in Notch and Wnt signaling | ||||
| Role of Calcineurin-dependent NFAT signaling in lymphocytes | ||||
| E-cadherin signaling in the nascent adherens junction | ||||
| Lissencephaly gene (LIS1) in neuronal migration and development | ||||
| PDGFR-alpha signaling pathway | ||||
| Signaling mediated by p38-alpha and p38-beta | ||||
| Alpha-synuclein signaling | ||||
| Reactome | Condensation of Prometaphase Chromosomes | |||
| WikiPathways | Mitotic Prometaphase | |||
| BDNF signaling pathway | ||||
| TNF alpha Signaling Pathway | ||||
| L1CAM interactions | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | CK2alpha and CK2alpha' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. Eur J Med Chem. 2012 Jan;47(1):345-50. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.